Connect with us

Cannabis News

North Carolina Hemp Businesses Brace For Impact Of New Federal THC Product Ban

Published

10 months ago

on

“We have a year to figure it out or we have a year to like it, crush it and fight for the plant and we hope to change that with the legislation.”

By Brandon Kingdollar, NC Newsline

For Hannah DeLange, the most rewarding aspect of running Redhead Hemp’s Durham location has been “creating a space where people feel comfortable and safe,” creating an inviting social atmosphere much like a coffee shop or bar.

Shelves are stocked with CBD gummies, Delta-9 sangrias and THC caramels, among other drinks and treats with promises like “sleep with benefits” and “lower calories, bigger vibes.”

The interior of the store looks cozy, with plants covering the brick walls with brightly colored artwork and plush sofas and chairs for relaxing. At the store’s “Canna Cafe,” customers can sit down with hemp-infused tea and coffee.

“It’s kind of a space for everybody,” DeLang said. “It has to be a plant for all people, and it has to be accessible, and to create a space that can really personify that.”

Now, the future of that space and many others like it are in jeopardy, with the majority of hemp-based cannabinoid products set to become illegal in November 2026.

Hemp business owners in North Carolina and their counterparts across the US are grappling with the impact of the ban, with some mounting advocacy efforts to reverse the ban and others working to narrow the range of CBD products that will remain legal.

“I think there is a lot of fear”

“We found out the morning of the Senate vote that this was happening,” said Emma MacAdam, owner of Redhead Hemp. “It was pretty clear when they put it in the bill that that bill was going to pass, so it just seemed like a vicious way for them to push their agenda into a bill that was so necessary and important to so many people.”

Hemp and marijuana are varieties of the cannabis plant, which differ mainly in levels of the psychoactive compound THC, with hemp containing much less. CBD, another chemical produced by the cannabis plant, does not have an intoxicating effect by itself, but it does produce a calming effect and has been shown to help treat pain and anxiety.

The ban, which significantly lowers the acceptable level of THC in hemp products, was passed earlier this week as part of a farm credit bill along with a stopgap funding deal to end the federal government shutdown.

It bans the sale of hemp products, including CBD products, that contain more than 0.4 milligrams of THC per container, DeLange and MacAdam said, about 99.5 percent of their stock. That would eliminate “full-spectrum” hemp products, which they said make up the most typical CBD products.

“They’re basically saying we can only use the non-intoxicating parts of the plant,” DeLange said. “For a lot of people, the compound THC, even that small amount that you see across the spectrum, that’s really important for pain relief, anxiety, sleep and things like that.”

DeLange said using CBD products has also helped some clients stop using opioids or stop drinking heavily. “Beverages have been a great resource for a lot of people who want a healthier alternative to that.”

The ban comes after lobbying by the marijuana industry and state law enforcement that the hemp industry exploited a loophole to sell products with many of marijuana’s effects but without regulatory oversight. The senators say they never intended to open up a recreational hemp market and only wanted to allow the cultivation of industrial hemp.

The reason, according to Sen. Mitch McConnell (R-Ky.) and other co-sponsors of the Farm Bill, is to “keep these dangerous products out of the hands of children, keeping the hemp industry to farmers,” and to do so, it closes a loophole that allows CBD products to be sold with less than 0.3 percent THC, a threshold that the Farm Bill originally helped overcome.

“Unfortunately, companies have exploited a loophole in the 2018 law by taking legal amounts of THC from hemp and turning it into an intoxicating substance, then marketing it to children in candy-like containers and selling it in easily accessible places like gas stations and convenience stores across our country,” McConnell said.

MacAdam and DeLange pushed back that the products are aimed at younger customers. They said their store has a strict 21+ policy.

“It’s very easy to use the iconic ‘save the children’ flag for a lot of things, I think there’s a lot of fear around cannabis – that’s the history of cannabis, period,” DeLange said.

“And there’s no talk of parental responsibility in that matter, or the fact that liquor isn’t safe for kids, and a lot of the new liquor companies are pretty and colorful,” MacAdam added. “I think it’s a complete escape.”

‘Wild West’

The rapid change to the ban represents a significant change for an industry that has seen little regulation in many states, including North Carolina, for the past seven years.

North Carolina has not enacted regulations on intoxicating hemp products, even with basic age restrictions, despite the support of the state Senate, Gov. Josh Stein (D) and Attorney General Jeff Jackson (D).

In February, the state’s child welfare task force reported a 600 percent increase in emergency room visits for minors related to cannabis use since 2019. Stein launched the Cannabis Products Advisory Council in June, saying “our state’s unregulated cannabis market is a wild west and is crying out for order.”

Last month, Jackson joined attorneys general in 38 states to ask Congress to regulate the sale of CBD products, asking lawmakers to “clarify the federal definition of hemp” during the appropriations process.

“Efforts by states to outlaw hemp-derived psychoactive products to protect their citizens cannot solve this problem,” the attorney general’s letter says. “Such efforts can only lead to unique and ineffective prohibitions and regulations that differ from state to state and will not stop the flood of THC mail order products from being transmitted through interstate commerce.”

Bills proposed in North Carolina that have not advanced this year include bans on sales to minors and sales permit requirements and child-friendly packaging and printed warnings. A bill passed by the Senate in June, which Jackson spoke for, would ban the sale of hemp-derived drinks, gummies and other products to anyone under 21 and prohibit their use on school grounds, among other rules, like a licensing process.

That bill and many others died in the powerful House Rules Committee, now chaired by Rep. John Bell (R-Wayne), who in 2024 became chairman of the hemp company Asterra Labs. Bell did not respond to multiple requests for comment for this story.

MacAdam said the lack of regulation has been a boon in some ways, such as making the industry more accessible to those with relatively few resources, creating greater opportunities for traditional business owners.

“It’s really nice when there’s no barrier to seeing what an industry can do. There’s no license that you have to pay $100,000 for. I started this business with a little money and a big goal, and I’m so grateful for all the people we’ve met along the way,” he said.

“It’s part of our way of life”

Also stopping are farm owners of flowering or smokeable hemp, a crop grown to make CBD products. Dana Rider, co-owner of Otherside Farm in rural Buncombe County, said the industry has been “disgusted” since hemp products were legalized in 2018 thanks to potential bans.

“We’d freak out and then everything would be fine, or they’d put it off for another year,” Rider said. “Obviously, (the ban) is going to strike a chord somewhere because, you know, it’s part of our livelihood.”

He said his family started growing hemp a year after starting their farm. Other farmers he knows have switched to hemp to revive their run-down tobacco farms and dairies. They now operate an online store, Otherside Hemp, and also sell their products in stores across the state. “It’s part of our income and helps keep the farm going,” he said.

He said that for many clients, the goal is not to undergo a chemical, but to manage pain and other conditions such as insomnia and anxiety.

“Your grandmother and your aunt and your parents don’t want to feel different, they don’t want to have that altered consciousness,” Rider said. “They just want to feel better.”

MacAdam and Rider both say they have been in conversation with other business owners who are working to push back against the ban before it goes into effect.

“We carry a lot of small businesses, a lot of family-run businesses, so we’re very concerned about our friends,” MacAdam said.

Otherside Farm plans to ask its supporters to contact state and local representatives about the ban, Rider said. “We have a year to figure it out or we have a year to like it, crush it and fight for the plant and we hope to change that with the legislation.”

“We will wait,” he added. “Until they tell us we can’t sell our stuff anymore, we’re going to keep selling our stuff and growing and producing our products.”

While some farms and shops will be able to continue to legally sell products processed to remove THC, also known as “CBD isolates,” Rider said his farm does not have the equipment to produce them. Since they only sell full-spectrum products, their entire product range would be wiped out by the ban.

“For us, we can’t really pivot, can we?” said Rider. “We wouldn’t be around anymore, basically, and that’s sad to think about.”

This story was first published by NC Newsline.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Related Topics:
Continue Reading

Cannabis News

Fluent to sell New York license and operations

Published

1 month ago

on

July 30, 2026

By











Fluent has entered into a definitive agreement to sell Etain, LLC, the Company’s New York-based operating entity. The purchase agreement was signed on July 22, 2026. The transaction provides for the sale of Etain’s Registered Entity license, certain of the Company’s New York operating assets and related New York leases for cash, subject to customary purchase price adjustments.

The Company believes the Transaction advances its strategic objectives and expects the Transaction to comply with applicable regulatory requirements in connection with the Company’s previously announced plan of arrangement for Vireo Growth Inc. (the “Deal”) while providing for an orderly transition of the New York operations to an experienced operator committed to serving patients and consumers.

Completion of the free transaction is subject to closing conditions, including, among other customary conditions, approval of the change in ownership by the New York State Cannabis Control Board and the completion of all conditions to the completion of the Agreement.

For more information:
FLUENT Corp
getfluent.com/










Continue Reading

Cannabis News

Marijuana Has ‘Horrific Health Risks’ And No Medical Value, Former Trump Attorney General Claims

Published

1 month ago

on

July 30, 2026

By

A former US attorney general who served in President Donald Trump’s first term says marijuana poses “tremendous health risks,” has no medical value and should not be rescheduled under federal law.

“Marijuana redistricting would create a false impression that it is safe, reduce penalties for illegally selling the drug, and provide a large tax windfall to those who legally supply it,” William Barr wrote in a Wednesday op-ed for The Washington Post, Kevin Sabet, CEO of the prohibitionist organization Smart Approaches to Marijuana. “That would be a disaster.”

The opinion comes as the Trump administration moves forward with cannabis reregulation.

According to an order issued in April by US Attorney General Todd Blanche, Marijuana products regulated by a state medical cannabis license were immediately changed from Schedule I As did marijuana products approved by the Food and Drug Administration (FDA) under Schedule III of the Controlled Substances Act (CSA).

an administrator The hearing is looking at the broader rescheduling of marijuanawith The Drug Enforcement Administration (DEA) has been tasked with advocating for cannabis reform highlighting the testimony about the medical benefits of marijuana and its relative safety compared to other substances such as alcohol and opioids. It included appearances by a Food and Drug Administration (FDA) scientist and a doctor from New Hampshire. Medical marijuana provides relief to pain patients and can serve as an alternative to opioids.

But Sabet and Barr, who served as Trump’s attorney general from 2019-2020, argued that “the evidence presented at the hearing did not support the rescheduling of marijuana” and instead “confirmed what decades of data have shown: raw marijuana has no scientifically established medical value and is highly susceptible to abuse.”

After the parties to the hearing have filed termination rights, the DEA administrative law judge overseeing the proceedings will make a recommendation regarding rescheduling, and the agency administrator will make a final decision.

DEA Administrator Terrance Cole only organizations and individuals opposed to marijuana reform have been invited to the hearing as a designated participant – telling supporters that they do not meet the definition of “interested person” to participate because they have not been “affected or prejudiced by any rule or proposed rule that may be issued.”

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

The former attorney general’s new opinion says “the stakes couldn’t be higher”, arguing that “marijuana today is more dangerous than ever” and that it is “addictive”, throwing out a list of alleged harm to mental and physical health.

“These unhealthy effects are a predictable result of a powerful and addictive drug being normalized, commercialized and marketed as a medicine,” Barr and Sabet say. “It would be one thing if marijuana had medical value. But there is no credible evidence that marijuana is an effective treatment for any medical condition, despite the millions of dollars spent trying to prove otherwise.”

The Department of Health and Human Services (HHS) published a 252 analysis in 2023 that concluded that marijuana had accepted medical value and should be rescheduled.

The new opposition piece also says that “rescheduling would unlock enormous revenue for the corporate marijuana industry by bringing it into a category that has not been covered by a longstanding reduction in federal drug tax deductions,” referring to a law known as 280E, which repeals Sections I and II.

“This, in turn, would allow the industry to spend even more on advertising and marketing to young people,” Barr and Sabet. he wroteArguing that “those who would lose this dragon in society are laying the foundations for another Big Tobacco”.

The Sabet organization, SAM, is one of several parties Challenging the Marijuana Redistricting Process which have been upheld by a federal Court of Appeals. those separate parts State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

SAM’s lawsuit was signed by attorneys at Torridon Law PLLC, where Barr is a partner.

The team announced in January that it was Hiring Barr’s firm to fight cannabis rescheduling After Trump signed an executive order directing officials to quickly complete the process.

During the first Trump administration, Barr was accused by a Justice Department official Directing improper anti-company investigations into multiple cannabis company mergers– Accounting for almost a third of the division’s cases in 2019.

Several Democratic members of Congress introduced a resolution calling for an investigation into Barr’s possible impeachment, saying “abused the power of his office” to improperly investigate marijuana businesses while engaging in other allegedly illegal conduct.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

How much red light does cannabis really need?

Published

1 month ago

on

July 26, 2026

By

When growers pull out two LED fixtures side by side, the first number they usually discuss is percent red. This is an easy specification to fix. They are efficient at producing red photons and incredibly efficient at photosynthesis, and cannabis eats away at the flower. So more red must be better, right?

Not so simple. Red is an input to a spectrum, and the spectrum is an input to a room. There is no single spectrum that wins everywhere. An indoor room pushes hard, a greenhouse that soaks up sunlight, a temperamental cultivar, and aggressive yields call for something different. Knowing what each light strip actually does allows you to choose a tool that fits your grow instead of one that just has a big number on the sales page.

© JumpLights

Blue: structure
Blue (approximately 400-500 nm) gives shape to the plant. It maintains dense growth, strong stems, tight internodes and allows it to develop as desired. It also encourages stomatal opening, so the plant manages water and gas exchange better. Get blue and you’ve built a plant that can carry heavy flowers with no problem.

Green: access
Green was eliminated as the wavelength is “reflected” by plants. It turns out that it does a real job. Blue and red are absorbed above; the green goes deep into the fat and reaches the leaves that are never touched by the above photons. In a compact room, it’s the difference between plants photosynthesising from the top down and those that work only from the top. Green won’t replace your red or blue, but it does carry usable light where they can’t reach.

Red: engine
Red is the horse of the flower. It absorbs as efficiently as anything in the spectrum, and is responsible for most of the biomass you’re after. Redder generally means faster flower development, more weight and better efficiency per watt.

But red has a ceiling, and it’s tied to what you run. Push PPFD upwards with a heavy red spectrum and some cultivars begin to whiten at the top: the flower should be dense with pale, washed tips. Genetics, intensity, barrel temperature and your general environment all feed into it. If you’re using aggressive light levels, a lower red spectrum will buy you room before that becomes a problem, leaving you almost no photosynthetic punch to get it.

Far Red: More than Emerson
Far-red (700-750 nm) appears in more devices every year. It contributes little to photosynthesis on its own, but it moves plant morphology and works with red through the Emerson Enhancement Effect. Used properly, it helps to deepen the light, encourage uniformity of the canopy and encourage the response of the bloom. The key word is small. A touch of far red rounds out a spectrum; he’s not there to make a show.

Matching the red percentage with the room
Cannabis addresses the entire spectrum, not a line on a spec sheet. Reds cause flowers, but blues, greens and crimsons give the plant something it needs. Where you land in red refers to how you grow.

A lower red spectrum (30-40%) captures more blue and green, gives you better morphology, reduces the risk of photobleaching, and holds up when you’re running extreme PPFD. Moderate spectrum (40-55%) is the sweet spot in commercial greenhouses: strong photosynthetic efficiency, strong flowering, balanced growth. A high-red spectrum (70%+) makes the most sense in a greenhouse, where the sun is already giving you lots of blue and green and your supplemental light can cast effective red to fill the gap.

Where does the ETS MAX series fit in?
This is the thinking behind the JumpLights ETS MAX series. Instead of forcing a spectrum into each room, it rarely comes up because a greenhouse and a high PPFD indoor flower room are not the same problem.

  • ETS MAX 4C41% red: for indoor rooms operating at very high intensity, where photobleaching is a real risk. The wider, red bottom balance allows you to push the tops without overcooking them
  • ETS MAX 4A48% red: balanced internal spectrum that maintains high output while controlling bleaching.
  • ETS MAX 5B57% Red: A high-performance indoor option. Moderate red, marked with efficiency and flower at the same time, up to 3,450 μmol/s, with efficiency that holds the spectrum.
  • ETS MAX 7A76% red: built for the greenhouse. The sun already supplies blue and green, so this leans heavily on the complementary red, up to 3,900 μmol/s in the infrastructure most greenhouses already have in place.

Bottom line
Choosing an activity is not a competition for the highest red number. The winning spectrum is the one that matches your environment, your intensity, your genetics, and what you’re trying to produce. Combine spectrum, intensity, environmental control, light distribution and genetics, and you’ve got a lighting strategy. Keep a spec isolated and all you’ve got is a bright room.

The ETS MAX line was created around this idea: choose the spectrum of the room you actually have, indoor or greenhouse, and let the device work with your grow rather than against it.

For more information:
JumpLights
www.jumplights.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media